Literature DB >> 21875065

Regio- and stereoselective syntheses of the natural product CCR5 antagonist anibamine and its three olefin isomers.

Feng Zhang1, Saheem Zaidi, Kendra M Haney, Glen E Kellogg, Yan Zhang.   

Abstract

The syntheses of the natural product anibamine and its three olefin isomers have been achieved concisely and efficiently via highly regio- and stereoselective reactions. The crucial steps included a regioselective palladium-catalyzed alkynylation by Sonogashira coupling and a stereoselective Suzuki coupling. Further conformation analyses and in vitro calcium mobilization studies were carried out to characterize the compounds' biological properties.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21875065      PMCID: PMC3197777          DOI: 10.1021/jo2013669

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  26 in total

Review 1.  New therapeutics that modulate chemokine networks.

Authors:  Matthias K Schwarz; Timothy N C Wells
Journal:  Nat Rev Drug Discov       Date:  2002-05       Impact factor: 84.694

Review 2.  HIV and the chemokine system: 10 years later.

Authors:  Paolo Lusso
Journal:  EMBO J       Date:  2006-01-26       Impact factor: 11.598

3.  The natural product CCR5 antagonist anibamine and its analogs as anti-prostate cancer agents.

Authors:  Kendra M Haney; Feng Zhang; Christopher K Arnatt; Yunyun Yuan; Guo Li; Joy L Ware; David A Gewirtz; Yan Zhang
Journal:  Bioorg Med Chem Lett       Date:  2011-07-23       Impact factor: 2.823

4.  Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene.

Authors:  M Samson; F Libert; B J Doranz; J Rucker; C Liesnard; C M Farber; S Saragosti; C Lapoumeroulie; J Cognaux; C Forceille; G Muyldermans; C Verhofstede; G Burtonboy; M Georges; T Imai; S Rana; Y Yi; R J Smyth; R G Collman; R W Doms; G Vassart; M Parmentier
Journal:  Nature       Date:  1996-08-22       Impact factor: 49.962

5.  Synthesis of Enantiomerically Pure Cyclopropanes from Cyclopropylboronic Acids.

Authors:  Joachim E. A. Luithle; Jörg Pietruszka
Journal:  J Org Chem       Date:  1999-10-29       Impact factor: 4.354

6.  2-pyrones possessing antimicrobial and cytotoxic activities.

Authors:  Ian J S Fairlamb; Lester R Marrison; Julia M Dickinson; Feng-Ju Lu; Jan Peter Schmidt
Journal:  Bioorg Med Chem       Date:  2004-08-01       Impact factor: 3.641

7.  Piperazine-based CCR5 antagonists as HIV-1 inhibitors. IV. Discovery of 1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]- 4-[4-[2-methoxy-1(R)-4-(trifluoromethyl)phenyl]ethyl-3(S)-methyl-1-piperazinyl]- 4-methylpiperidine (Sch-417690/Sch-D), a potent, highly selective, and orally bioavailable CCR5 antagonist.

Authors:  Jayaram R Tagat; Stuart W McCombie; Dennis Nazareno; Marc A Labroli; Yushi Xiao; Ruo W Steensma; Julie M Strizki; Bahige M Baroudy; Kathleen Cox; Jean Lachowicz; Geoffrey Varty; Robert Watkins
Journal:  J Med Chem       Date:  2004-05-06       Impact factor: 7.446

8.  A chemokine receptor antagonist inhibits experimental breast tumor growth.

Authors:  Stephen C Robinson; Kate A Scott; Julia L Wilson; Richard G Thompson; Amanda E I Proudfoot; Frances R Balkwill
Journal:  Cancer Res       Date:  2003-12-01       Impact factor: 12.701

Review 9.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

10.  Spirodiketopiperazine-based CCR5 inhibitor which preserves CC-chemokine/CCR5 interactions and exerts potent activity against R5 human immunodeficiency virus type 1 in vitro.

Authors:  Kenji Maeda; Hirotomo Nakata; Yasuhiro Koh; Toshikazu Miyakawa; Hiromi Ogata; Yoshikazu Takaoka; Shiro Shibayama; Kenji Sagawa; Daikichi Fukushima; Joseph Moravek; Yoshio Koyanagi; Hiroaki Mitsuya
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

View more
  1 in total

1.  Anibamine and Its Analogues: Potent Antiplasmodial Agents from Aniba citrifolia.

Authors:  Yongle Du; Ana Lisa Valenciano; Yumin Dai; Yi Zheng; Feng Zhang; Yan Zhang; Jason Clement; Michael Goetz; David G I Kingston; Maria B Cassera
Journal:  J Nat Prod       Date:  2019-10-02       Impact factor: 4.050

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.